nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1A1—kidney cancer	0.252	1	CbGaD
Melatonin—CYP1B1—Erlotinib—kidney cancer	0.0677	0.202	CbGbCtD
Melatonin—CYP1B1—Paclitaxel—kidney cancer	0.0619	0.185	CbGbCtD
Melatonin—CYP19A1—Paclitaxel—kidney cancer	0.0502	0.15	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—kidney cancer	0.0334	0.0995	CbGbCtD
Melatonin—CYP1A1—Erlotinib—kidney cancer	0.0297	0.0885	CbGbCtD
Melatonin—CYP1A2—Pazopanib—kidney cancer	0.0186	0.0554	CbGbCtD
Melatonin—CYP2C9—Capecitabine—kidney cancer	0.0175	0.0521	CbGbCtD
Melatonin—CYP1A2—Erlotinib—kidney cancer	0.0133	0.0396	CbGbCtD
Melatonin—CYP2C19—Sorafenib—kidney cancer	0.0117	0.0349	CbGbCtD
Melatonin—CYP2C9—Paclitaxel—kidney cancer	0.0109	0.0326	CbGbCtD
Melatonin—CYP1A2—Sorafenib—kidney cancer	0.0108	0.0322	CbGbCtD
Melatonin—CYP2C9—Sorafenib—kidney cancer	0.00972	0.029	CbGbCtD
Melatonin—SLC22A8—nephron—kidney cancer	0.00407	0.0651	CbGeAlD
Melatonin—ASMT—gonad—kidney cancer	0.00385	0.0615	CbGeAlD
Melatonin—SLC22A8—urine—kidney cancer	0.00327	0.0522	CbGeAlD
Melatonin—CYP2C19—urine—kidney cancer	0.00274	0.0438	CbGeAlD
Melatonin—CALR—nephron tubule—kidney cancer	0.00253	0.0405	CbGeAlD
Melatonin—CALR—renal system—kidney cancer	0.0023	0.0368	CbGeAlD
Melatonin—CYP1A2—urine—kidney cancer	0.00224	0.0357	CbGeAlD
Melatonin—CALR—kidney—kidney cancer	0.00223	0.0356	CbGeAlD
Melatonin—CALR—cortex of kidney—kidney cancer	0.00217	0.0346	CbGeAlD
Melatonin—CYP2C9—urine—kidney cancer	0.00212	0.0339	CbGeAlD
Melatonin—CALR—gonad—kidney cancer	0.00206	0.033	CbGeAlD
Melatonin—CALR—cardiac atrium—kidney cancer	0.00206	0.0329	CbGeAlD
Melatonin—NQO2—nephron tubule—kidney cancer	0.00143	0.0228	CbGeAlD
Melatonin—NQO2—renal system—kidney cancer	0.0013	0.0208	CbGeAlD
Melatonin—NQO2—kidney—kidney cancer	0.00126	0.0201	CbGeAlD
Melatonin—NQO2—cortex of kidney—kidney cancer	0.00122	0.0195	CbGeAlD
Melatonin—NQO2—cardiac atrium—kidney cancer	0.00116	0.0186	CbGeAlD
Melatonin—MPO—renal system—kidney cancer	0.001	0.016	CbGeAlD
Melatonin—CALM3—nephron tubule—kidney cancer	0.000988	0.0158	CbGeAlD
Melatonin—MPO—kidney—kidney cancer	0.000966	0.0154	CbGeAlD
Melatonin—Nabumetone—PTGS1—kidney cancer	0.000957	0.541	CrCbGaD
Melatonin—SLC22A8—nephron tubule—kidney cancer	0.000879	0.014	CbGeAlD
Melatonin—CALM3—cortex of kidney—kidney cancer	0.000846	0.0135	CbGeAlD
Melatonin—CYP1B1—nephron tubule—kidney cancer	0.00084	0.0134	CbGeAlD
Melatonin—CALM3—cardiac atrium—kidney cancer	0.000805	0.0129	CbGeAlD
Melatonin—SLC22A8—renal system—kidney cancer	0.000799	0.0128	CbGeAlD
Melatonin—CALM2—nephron tubule—kidney cancer	0.000776	0.0124	CbGeAlD
Melatonin—CALM1—nephron tubule—kidney cancer	0.000773	0.0123	CbGeAlD
Melatonin—SLC22A8—kidney—kidney cancer	0.000773	0.0123	CbGeAlD
Melatonin—CYP1B1—renal system—kidney cancer	0.000764	0.0122	CbGeAlD
Melatonin—SLC22A8—cortex of kidney—kidney cancer	0.000752	0.012	CbGeAlD
Melatonin—CYP1B1—kidney—kidney cancer	0.000738	0.0118	CbGeAlD
Melatonin—CYP19A1—gonad—kidney cancer	0.000732	0.0117	CbGeAlD
Melatonin—CYP1B1—cortex of kidney—kidney cancer	0.000719	0.0115	CbGeAlD
Melatonin—ESR1—renal system—kidney cancer	0.00071	0.0113	CbGeAlD
Melatonin—CALM2—renal system—kidney cancer	0.000706	0.0113	CbGeAlD
Melatonin—CALM1—renal system—kidney cancer	0.000702	0.0112	CbGeAlD
Melatonin—ESR1—kidney—kidney cancer	0.000686	0.011	CbGeAlD
Melatonin—CYP1B1—gonad—kidney cancer	0.000685	0.0109	CbGeAlD
Melatonin—CALM2—kidney—kidney cancer	0.000682	0.0109	CbGeAlD
Melatonin—CALM1—kidney—kidney cancer	0.000679	0.0108	CbGeAlD
Melatonin—CALM2—cortex of kidney—kidney cancer	0.000664	0.0106	CbGeAlD
Melatonin—CALM1—cortex of kidney—kidney cancer	0.000661	0.0106	CbGeAlD
Melatonin—ESR1—gonad—kidney cancer	0.000637	0.0102	CbGeAlD
Melatonin—CALM2—gonad—kidney cancer	0.000633	0.0101	CbGeAlD
Melatonin—CALM2—cardiac atrium—kidney cancer	0.000632	0.0101	CbGeAlD
Melatonin—CALM1—gonad—kidney cancer	0.00063	0.0101	CbGeAlD
Melatonin—CALM1—cardiac atrium—kidney cancer	0.000629	0.01	CbGeAlD
Melatonin—Nabumetone—PTGS2—kidney cancer	0.000547	0.309	CrCbGaD
Melatonin—CYP1A2—renal system—kidney cancer	0.000547	0.00874	CbGeAlD
Melatonin—CYP1A1—renal system—kidney cancer	0.00054	0.00862	CbGeAlD
Melatonin—CYP1A1—kidney—kidney cancer	0.000522	0.00834	CbGeAlD
Melatonin—CYP1A1—cardiac atrium—kidney cancer	0.000483	0.00772	CbGeAlD
Melatonin—Sumatriptan—ABCB1—kidney cancer	0.000264	0.149	CrCbGaD
Melatonin—Haematuria—Capecitabine—kidney cancer	0.000142	0.000725	CcSEcCtD
Melatonin—Erythema—Paclitaxel—kidney cancer	0.000142	0.000724	CcSEcCtD
Melatonin—Malnutrition—Paclitaxel—kidney cancer	0.000142	0.000724	CcSEcCtD
Melatonin—Abdominal pain—Sorafenib—kidney cancer	0.000142	0.000722	CcSEcCtD
Melatonin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000141	0.000719	CcSEcCtD
Melatonin—Hepatobiliary disease—Capecitabine—kidney cancer	0.000141	0.000719	CcSEcCtD
Melatonin—Pruritus—Erlotinib—kidney cancer	0.000141	0.000719	CcSEcCtD
Melatonin—Fatigue—Dactinomycin—kidney cancer	0.000141	0.000718	CcSEcCtD
Melatonin—Flatulence—Paclitaxel—kidney cancer	0.00014	0.000713	CcSEcCtD
Melatonin—Pain—Dactinomycin—kidney cancer	0.00014	0.000712	CcSEcCtD
Melatonin—Tension—Paclitaxel—kidney cancer	0.000139	0.00071	CcSEcCtD
Melatonin—Eczema—Doxorubicin—kidney cancer	0.000139	0.000708	CcSEcCtD
Melatonin—Nervousness—Paclitaxel—kidney cancer	0.000138	0.000703	CcSEcCtD
Melatonin—Infection—Gemcitabine—kidney cancer	0.000138	0.000701	CcSEcCtD
Melatonin—Back pain—Paclitaxel—kidney cancer	0.000137	0.0007	CcSEcCtD
Melatonin—Dizziness—Vinblastine—kidney cancer	0.000137	0.000699	CcSEcCtD
Melatonin—Dizziness—Everolimus—kidney cancer	0.000137	0.000696	CcSEcCtD
Melatonin—Muscle spasms—Paclitaxel—kidney cancer	0.000137	0.000696	CcSEcCtD
Melatonin—Abdominal pain—Sunitinib—kidney cancer	0.000136	0.000695	CcSEcCtD
Melatonin—Nervous system disorder—Gemcitabine—kidney cancer	0.000136	0.000692	CcSEcCtD
Melatonin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000136	0.000691	CcSEcCtD
Melatonin—Skin disorder—Gemcitabine—kidney cancer	0.000134	0.000685	CcSEcCtD
Melatonin—Vision blurred—Paclitaxel—kidney cancer	0.000134	0.000682	CcSEcCtD
Melatonin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000134	0.000681	CcSEcCtD
Melatonin—Hot flush—Doxorubicin—kidney cancer	0.000133	0.00068	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000133	0.000678	CcSEcCtD
Melatonin—Urinary tract disorder—Capecitabine—kidney cancer	0.000132	0.000674	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—kidney cancer	0.000132	0.000674	CcSEcCtD
Melatonin—Hypersensitivity—Sorafenib—kidney cancer	0.000132	0.000673	CcSEcCtD
Melatonin—Insomnia—Vincristine—kidney cancer	0.000132	0.000673	CcSEcCtD
Melatonin—Vomiting—Vinblastine—kidney cancer	0.000132	0.000672	CcSEcCtD
Melatonin—Dizziness—Erlotinib—kidney cancer	0.000132	0.000672	CcSEcCtD
Melatonin—Connective tissue disorder—Capecitabine—kidney cancer	0.000132	0.000671	CcSEcCtD
Melatonin—Vomiting—Everolimus—kidney cancer	0.000131	0.000669	CcSEcCtD
Melatonin—Urethral disorder—Capecitabine—kidney cancer	0.000131	0.000669	CcSEcCtD
Melatonin—Paraesthesia—Vincristine—kidney cancer	0.000131	0.000668	CcSEcCtD
Melatonin—Agitation—Paclitaxel—kidney cancer	0.000131	0.000665	CcSEcCtD
Melatonin—Rash—Everolimus—kidney cancer	0.00013	0.000664	CcSEcCtD
Melatonin—Dermatitis—Everolimus—kidney cancer	0.00013	0.000663	CcSEcCtD
Melatonin—Headache—Vinblastine—kidney cancer	0.00013	0.000662	CcSEcCtD
Melatonin—Angioedema—Paclitaxel—kidney cancer	0.00013	0.000661	CcSEcCtD
Melatonin—Headache—Everolimus—kidney cancer	0.000129	0.00066	CcSEcCtD
Melatonin—Abdominal pain—Dactinomycin—kidney cancer	0.000129	0.000658	CcSEcCtD
Melatonin—Asthenia—Sorafenib—kidney cancer	0.000129	0.000656	CcSEcCtD
Melatonin—Vertigo—Paclitaxel—kidney cancer	0.000128	0.00065	CcSEcCtD
Melatonin—Syncope—Paclitaxel—kidney cancer	0.000127	0.000649	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—kidney cancer	0.000127	0.000649	CcSEcCtD
Melatonin—Leukopenia—Paclitaxel—kidney cancer	0.000127	0.000648	CcSEcCtD
Melatonin—Hypersensitivity—Sunitinib—kidney cancer	0.000127	0.000648	CcSEcCtD
Melatonin—Pruritus—Sorafenib—kidney cancer	0.000127	0.000647	CcSEcCtD
Melatonin—Vomiting—Erlotinib—kidney cancer	0.000127	0.000646	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000126	0.000643	CcSEcCtD
Melatonin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000126	0.000642	CcSEcCtD
Melatonin—Fatigue—Vincristine—kidney cancer	0.000126	0.000641	CcSEcCtD
Melatonin—Rash—Erlotinib—kidney cancer	0.000126	0.00064	CcSEcCtD
Melatonin—Dermatitis—Erlotinib—kidney cancer	0.000126	0.00064	CcSEcCtD
Melatonin—Palpitations—Paclitaxel—kidney cancer	0.000125	0.00064	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—kidney cancer	0.000125	0.000638	CcSEcCtD
Melatonin—Insomnia—Gemcitabine—kidney cancer	0.000125	0.000638	CcSEcCtD
Melatonin—Eye disorder—Capecitabine—kidney cancer	0.000125	0.000638	CcSEcCtD
Melatonin—Headache—Erlotinib—kidney cancer	0.000125	0.000636	CcSEcCtD
Melatonin—Loss of consciousness—Paclitaxel—kidney cancer	0.000125	0.000636	CcSEcCtD
Melatonin—Pain—Vincristine—kidney cancer	0.000125	0.000636	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—kidney cancer	0.000125	0.000636	CcSEcCtD
Melatonin—Paraesthesia—Gemcitabine—kidney cancer	0.000124	0.000634	CcSEcCtD
Melatonin—Cardiac disorder—Capecitabine—kidney cancer	0.000124	0.000633	CcSEcCtD
Melatonin—Asthenia—Sunitinib—kidney cancer	0.000124	0.000631	CcSEcCtD
Melatonin—Nausea—Vinblastine—kidney cancer	0.000123	0.000628	CcSEcCtD
Melatonin—Somnolence—Gemcitabine—kidney cancer	0.000123	0.000627	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—kidney cancer	0.000123	0.000626	CcSEcCtD
Melatonin—Migraine—Doxorubicin—kidney cancer	0.000123	0.000626	CcSEcCtD
Melatonin—Nausea—Everolimus—kidney cancer	0.000123	0.000625	CcSEcCtD
Melatonin—Hypertension—Paclitaxel—kidney cancer	0.000123	0.000625	CcSEcCtD
Melatonin—Pruritus—Sunitinib—kidney cancer	0.000122	0.000622	CcSEcCtD
Melatonin—Angiopathy—Capecitabine—kidney cancer	0.000121	0.000619	CcSEcCtD
Melatonin—Immune system disorder—Capecitabine—kidney cancer	0.000121	0.000616	CcSEcCtD
Melatonin—Chest pain—Paclitaxel—kidney cancer	0.000121	0.000616	CcSEcCtD
Melatonin—Arthralgia—Paclitaxel—kidney cancer	0.000121	0.000616	CcSEcCtD
Melatonin—Anxiety—Paclitaxel—kidney cancer	0.00012	0.000614	CcSEcCtD
Melatonin—Hypersensitivity—Dactinomycin—kidney cancer	0.00012	0.000613	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00012	0.000612	CcSEcCtD
Melatonin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00012	0.000609	CcSEcCtD
Melatonin—Fatigue—Gemcitabine—kidney cancer	0.000119	0.000608	CcSEcCtD
Melatonin—Gastrointestinal pain—Vincristine—kidney cancer	0.000119	0.000608	CcSEcCtD
Melatonin—Dizziness—Sorafenib—kidney cancer	0.000119	0.000604	CcSEcCtD
Melatonin—Pain—Gemcitabine—kidney cancer	0.000118	0.000603	CcSEcCtD
Melatonin—Nausea—Erlotinib—kidney cancer	0.000118	0.000603	CcSEcCtD
Melatonin—Dry mouth—Paclitaxel—kidney cancer	0.000118	0.000603	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—kidney cancer	0.000118	0.000602	CcSEcCtD
Melatonin—Mental disorder—Capecitabine—kidney cancer	0.000117	0.000598	CcSEcCtD
Melatonin—Asthenia—Dactinomycin—kidney cancer	0.000117	0.000597	CcSEcCtD
Melatonin—Malnutrition—Capecitabine—kidney cancer	0.000117	0.000594	CcSEcCtD
Melatonin—Erythema—Capecitabine—kidney cancer	0.000117	0.000594	CcSEcCtD
Melatonin—Abdominal pain—Vincristine—kidney cancer	0.000115	0.000588	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—kidney cancer	0.000115	0.000587	CcSEcCtD
Melatonin—Infection—Paclitaxel—kidney cancer	0.000115	0.000587	CcSEcCtD
Melatonin—Flatulence—Capecitabine—kidney cancer	0.000115	0.000585	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—kidney cancer	0.000114	0.000583	CcSEcCtD
Melatonin—Dizziness—Sunitinib—kidney cancer	0.000114	0.000582	CcSEcCtD
Melatonin—Shock—Paclitaxel—kidney cancer	0.000114	0.000581	CcSEcCtD
Melatonin—Vomiting—Sorafenib—kidney cancer	0.000114	0.000581	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000114	0.000581	CcSEcCtD
Melatonin—Nervous system disorder—Paclitaxel—kidney cancer	0.000114	0.000579	CcSEcCtD
Melatonin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000113	0.000578	CcSEcCtD
Melatonin—Rash—Sorafenib—kidney cancer	0.000113	0.000576	CcSEcCtD
Melatonin—Dermatitis—Sorafenib—kidney cancer	0.000113	0.000576	CcSEcCtD
Melatonin—Back pain—Capecitabine—kidney cancer	0.000113	0.000575	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—kidney cancer	0.000113	0.000575	CcSEcCtD
Melatonin—Skin disorder—Paclitaxel—kidney cancer	0.000113	0.000574	CcSEcCtD
Melatonin—Headache—Sorafenib—kidney cancer	0.000112	0.000573	CcSEcCtD
Melatonin—Muscle spasms—Capecitabine—kidney cancer	0.000112	0.000571	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000112	0.000569	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—kidney cancer	0.00011	0.000563	CcSEcCtD
Melatonin—Vision blurred—Capecitabine—kidney cancer	0.00011	0.00056	CcSEcCtD
Melatonin—Vomiting—Sunitinib—kidney cancer	0.00011	0.000559	CcSEcCtD
Melatonin—Rash—Sunitinib—kidney cancer	0.000109	0.000554	CcSEcCtD
Melatonin—Dermatitis—Sunitinib—kidney cancer	0.000109	0.000554	CcSEcCtD
Melatonin—Headache—Sunitinib—kidney cancer	0.000108	0.000551	CcSEcCtD
Melatonin—Hypersensitivity—Vincristine—kidney cancer	0.000108	0.000548	CcSEcCtD
Melatonin—Nausea—Sorafenib—kidney cancer	0.000106	0.000543	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000106	0.000538	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—kidney cancer	0.000105	0.000535	CcSEcCtD
Melatonin—Insomnia—Paclitaxel—kidney cancer	0.000105	0.000534	CcSEcCtD
Melatonin—Vertigo—Capecitabine—kidney cancer	0.000105	0.000534	CcSEcCtD
Melatonin—Asthenia—Vincristine—kidney cancer	0.000105	0.000534	CcSEcCtD
Melatonin—Syncope—Capecitabine—kidney cancer	0.000105	0.000533	CcSEcCtD
Melatonin—Leukopenia—Capecitabine—kidney cancer	0.000104	0.000532	CcSEcCtD
Melatonin—Paraesthesia—Paclitaxel—kidney cancer	0.000104	0.00053	CcSEcCtD
Melatonin—Vomiting—Dactinomycin—kidney cancer	0.000104	0.000529	CcSEcCtD
Melatonin—Somnolence—Paclitaxel—kidney cancer	0.000103	0.000525	CcSEcCtD
Melatonin—Palpitations—Capecitabine—kidney cancer	0.000103	0.000525	CcSEcCtD
Melatonin—Rash—Dactinomycin—kidney cancer	0.000103	0.000525	CcSEcCtD
Melatonin—Nausea—Sunitinib—kidney cancer	0.000102	0.000522	CcSEcCtD
Melatonin—Loss of consciousness—Capecitabine—kidney cancer	0.000102	0.000522	CcSEcCtD
Melatonin—Dyspepsia—Paclitaxel—kidney cancer	0.000102	0.00052	CcSEcCtD
Melatonin—Hypertension—Capecitabine—kidney cancer	0.000101	0.000513	CcSEcCtD
Melatonin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.0001	0.00051	CcSEcCtD
Melatonin—Fatigue—Paclitaxel—kidney cancer	9.99e-05	0.000509	CcSEcCtD
Melatonin—Asthenia—Gemcitabine—kidney cancer	9.93e-05	0.000506	CcSEcCtD
Melatonin—Chest pain—Capecitabine—kidney cancer	9.92e-05	0.000506	CcSEcCtD
Melatonin—Arthralgia—Capecitabine—kidney cancer	9.92e-05	0.000506	CcSEcCtD
Melatonin—Pain—Paclitaxel—kidney cancer	9.91e-05	0.000505	CcSEcCtD
Melatonin—Anxiety—Capecitabine—kidney cancer	9.89e-05	0.000504	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.85e-05	0.000502	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—kidney cancer	9.81e-05	0.0005	CcSEcCtD
Melatonin—Pruritus—Gemcitabine—kidney cancer	9.79e-05	0.000499	CcSEcCtD
Melatonin—Dry mouth—Capecitabine—kidney cancer	9.7e-05	0.000495	CcSEcCtD
Melatonin—Nausea—Dactinomycin—kidney cancer	9.7e-05	0.000494	CcSEcCtD
Melatonin—Dizziness—Vincristine—kidney cancer	9.65e-05	0.000492	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—kidney cancer	9.61e-05	0.00049	CcSEcCtD
Melatonin—Infestation—Doxorubicin—kidney cancer	9.61e-05	0.00049	CcSEcCtD
Melatonin—Gastrointestinal pain—Paclitaxel—kidney cancer	9.48e-05	0.000483	CcSEcCtD
Melatonin—Infection—Capecitabine—kidney cancer	9.45e-05	0.000482	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—kidney cancer	9.37e-05	0.000478	CcSEcCtD
Melatonin—Shock—Capecitabine—kidney cancer	9.36e-05	0.000477	CcSEcCtD
Melatonin—Nervous system disorder—Capecitabine—kidney cancer	9.33e-05	0.000475	CcSEcCtD
Melatonin—Thrombocytopenia—Capecitabine—kidney cancer	9.31e-05	0.000475	CcSEcCtD
Melatonin—Vomiting—Vincristine—kidney cancer	9.28e-05	0.000473	CcSEcCtD
Melatonin—Skin disorder—Capecitabine—kidney cancer	9.24e-05	0.000471	CcSEcCtD
Melatonin—Rash—Vincristine—kidney cancer	9.2e-05	0.000469	CcSEcCtD
Melatonin—Dermatitis—Vincristine—kidney cancer	9.19e-05	0.000469	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—kidney cancer	9.17e-05	0.000467	CcSEcCtD
Melatonin—Abdominal pain—Paclitaxel—kidney cancer	9.16e-05	0.000467	CcSEcCtD
Melatonin—Headache—Vincristine—kidney cancer	9.14e-05	0.000466	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—kidney cancer	9.09e-05	0.000463	CcSEcCtD
Melatonin—Vomiting—Gemcitabine—kidney cancer	8.8e-05	0.000449	CcSEcCtD
Melatonin—Rash—Gemcitabine—kidney cancer	8.73e-05	0.000445	CcSEcCtD
Melatonin—Dermatitis—Gemcitabine—kidney cancer	8.72e-05	0.000444	CcSEcCtD
Melatonin—Headache—Gemcitabine—kidney cancer	8.67e-05	0.000442	CcSEcCtD
Melatonin—Nausea—Vincristine—kidney cancer	8.67e-05	0.000442	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.67e-05	0.000442	CcSEcCtD
Melatonin—Insomnia—Capecitabine—kidney cancer	8.6e-05	0.000438	CcSEcCtD
Melatonin—Paraesthesia—Capecitabine—kidney cancer	8.54e-05	0.000435	CcSEcCtD
Melatonin—Hypersensitivity—Paclitaxel—kidney cancer	8.54e-05	0.000435	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—kidney cancer	8.52e-05	0.000434	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—kidney cancer	8.48e-05	0.000432	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—kidney cancer	8.46e-05	0.000431	CcSEcCtD
Melatonin—Dyspepsia—Capecitabine—kidney cancer	8.37e-05	0.000427	CcSEcCtD
Melatonin—Asthenia—Paclitaxel—kidney cancer	8.32e-05	0.000424	CcSEcCtD
Melatonin—Nausea—Gemcitabine—kidney cancer	8.22e-05	0.000419	CcSEcCtD
Melatonin—Gastrointestinal disorder—Capecitabine—kidney cancer	8.21e-05	0.000419	CcSEcCtD
Melatonin—Fatigue—Capecitabine—kidney cancer	8.2e-05	0.000418	CcSEcCtD
Melatonin—Pruritus—Paclitaxel—kidney cancer	8.2e-05	0.000418	CcSEcCtD
Melatonin—Pain—Capecitabine—kidney cancer	8.13e-05	0.000415	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—kidney cancer	8.06e-05	0.000411	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—kidney cancer	8.01e-05	0.000408	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—kidney cancer	7.83e-05	0.000399	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—kidney cancer	7.79e-05	0.000397	CcSEcCtD
Melatonin—Gastrointestinal pain—Capecitabine—kidney cancer	7.78e-05	0.000396	CcSEcCtD
Melatonin—Dizziness—Paclitaxel—kidney cancer	7.66e-05	0.000391	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—kidney cancer	7.56e-05	0.000385	CcSEcCtD
Melatonin—Abdominal pain—Capecitabine—kidney cancer	7.52e-05	0.000383	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—kidney cancer	7.51e-05	0.000383	CcSEcCtD
Melatonin—Erythema—Doxorubicin—kidney cancer	7.51e-05	0.000383	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—kidney cancer	7.4e-05	0.000377	CcSEcCtD
Melatonin—Tension—Doxorubicin—kidney cancer	7.37e-05	0.000376	CcSEcCtD
Melatonin—Vomiting—Paclitaxel—kidney cancer	7.37e-05	0.000376	CcSEcCtD
Melatonin—Rash—Paclitaxel—kidney cancer	7.31e-05	0.000372	CcSEcCtD
Melatonin—Dermatitis—Paclitaxel—kidney cancer	7.3e-05	0.000372	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—kidney cancer	7.3e-05	0.000372	CcSEcCtD
Melatonin—Back pain—Doxorubicin—kidney cancer	7.27e-05	0.00037	CcSEcCtD
Melatonin—Headache—Paclitaxel—kidney cancer	7.26e-05	0.00037	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—kidney cancer	7.22e-05	0.000368	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—kidney cancer	7.08e-05	0.000361	CcSEcCtD
Melatonin—Hypersensitivity—Capecitabine—kidney cancer	7.01e-05	0.000357	CcSEcCtD
Melatonin—Agitation—Doxorubicin—kidney cancer	6.9e-05	0.000352	CcSEcCtD
Melatonin—Nausea—Paclitaxel—kidney cancer	6.88e-05	0.000351	CcSEcCtD
Melatonin—Asthenia—Capecitabine—kidney cancer	6.82e-05	0.000348	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—kidney cancer	6.75e-05	0.000344	CcSEcCtD
Melatonin—Syncope—Doxorubicin—kidney cancer	6.74e-05	0.000343	CcSEcCtD
Melatonin—Pruritus—Capecitabine—kidney cancer	6.73e-05	0.000343	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—kidney cancer	6.72e-05	0.000343	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—kidney cancer	6.64e-05	0.000338	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—kidney cancer	6.6e-05	0.000337	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—kidney cancer	6.49e-05	0.000331	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—kidney cancer	6.4e-05	0.000326	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—kidney cancer	6.4e-05	0.000326	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—kidney cancer	6.37e-05	0.000325	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.35e-05	0.000324	CcSEcCtD
Melatonin—Dizziness—Capecitabine—kidney cancer	6.29e-05	0.000321	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—kidney cancer	6.25e-05	0.000319	CcSEcCtD
Melatonin—Infection—Doxorubicin—kidney cancer	6.09e-05	0.00031	CcSEcCtD
Melatonin—Vomiting—Capecitabine—kidney cancer	6.05e-05	0.000308	CcSEcCtD
Melatonin—Shock—Doxorubicin—kidney cancer	6.03e-05	0.000307	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—kidney cancer	6.01e-05	0.000306	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—kidney cancer	6e-05	0.000306	CcSEcCtD
Melatonin—Rash—Capecitabine—kidney cancer	6e-05	0.000306	CcSEcCtD
Melatonin—Dermatitis—Capecitabine—kidney cancer	5.99e-05	0.000305	CcSEcCtD
Melatonin—Headache—Capecitabine—kidney cancer	5.96e-05	0.000304	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—kidney cancer	5.96e-05	0.000304	CcSEcCtD
Melatonin—Nausea—Capecitabine—kidney cancer	5.65e-05	0.000288	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.59e-05	0.000285	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—kidney cancer	5.55e-05	0.000283	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—kidney cancer	5.51e-05	0.000281	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—kidney cancer	5.45e-05	0.000278	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—kidney cancer	5.4e-05	0.000275	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.29e-05	0.00027	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—kidney cancer	5.29e-05	0.000269	CcSEcCtD
Melatonin—Pain—Doxorubicin—kidney cancer	5.24e-05	0.000267	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—kidney cancer	5.01e-05	0.000256	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—kidney cancer	4.85e-05	0.000247	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—kidney cancer	4.52e-05	0.00023	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—kidney cancer	4.4e-05	0.000224	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—kidney cancer	4.34e-05	0.000221	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—kidney cancer	4.05e-05	0.000207	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—kidney cancer	3.9e-05	0.000199	CcSEcCtD
Melatonin—Rash—Doxorubicin—kidney cancer	3.87e-05	0.000197	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—kidney cancer	3.86e-05	0.000197	CcSEcCtD
Melatonin—Headache—Doxorubicin—kidney cancer	3.84e-05	0.000196	CcSEcCtD
Melatonin—Nausea—Doxorubicin—kidney cancer	3.64e-05	0.000186	CcSEcCtD
Melatonin—CALM2—Hemostasis—TP53—kidney cancer	3.73e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—kidney cancer	3.73e-06	2.45e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ABCB1—kidney cancer	3.73e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—RAF1—kidney cancer	3.72e-06	2.44e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—RAF1—kidney cancer	3.72e-06	2.44e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.68e-06	2.41e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTEN—kidney cancer	3.67e-06	2.41e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.65e-06	2.39e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KRAS—kidney cancer	3.63e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KRAS—kidney cancer	3.63e-06	2.38e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—GSTM1—kidney cancer	3.62e-06	2.37e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—MAPK3—kidney cancer	3.61e-06	2.37e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GSTP1—kidney cancer	3.59e-06	2.36e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—PIK3CA—kidney cancer	3.59e-06	2.36e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.57e-06	2.34e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTEN—kidney cancer	3.53e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—RAF1—kidney cancer	3.52e-06	2.31e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—MYC—kidney cancer	3.51e-06	2.3e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—RELA—kidney cancer	3.5e-06	2.3e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—ERBB2—kidney cancer	3.48e-06	2.28e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—PIK3CA—kidney cancer	3.47e-06	2.28e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—PIK3CA—kidney cancer	3.47e-06	2.28e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL2—kidney cancer	3.45e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—PIK3CA—kidney cancer	3.45e-06	2.26e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.45e-06	2.26e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.43e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MTOR—kidney cancer	3.43e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD4—kidney cancer	3.43e-06	2.25e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ABCB1—kidney cancer	3.4e-06	2.23e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—RAF1—kidney cancer	3.4e-06	2.23e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—RAF1—kidney cancer	3.4e-06	2.23e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—RELA—kidney cancer	3.39e-06	2.22e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—RELA—kidney cancer	3.39e-06	2.22e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—ERBB2—kidney cancer	3.36e-06	2.21e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—ERBB2—kidney cancer	3.36e-06	2.21e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL2—kidney cancer	3.34e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL2—kidney cancer	3.34e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—PIK3CA—kidney cancer	3.34e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—PIK3CA—kidney cancer	3.34e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MTOR—kidney cancer	3.32e-06	2.18e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MTOR—kidney cancer	3.32e-06	2.18e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD4—kidney cancer	3.31e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD4—kidney cancer	3.31e-06	2.17e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GSTM1—kidney cancer	3.3e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—POMC—kidney cancer	3.3e-06	2.16e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HIF1A—kidney cancer	3.29e-06	2.16e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TSC2—kidney cancer	3.28e-06	2.15e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—RAF1—kidney cancer	3.26e-06	2.13e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—RAF1—kidney cancer	3.25e-06	2.13e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—RELA—kidney cancer	3.24e-06	2.13e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CDKN1B—kidney cancer	3.22e-06	2.11e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—ERBB2—kidney cancer	3.22e-06	2.11e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—ERBB2—kidney cancer	3.21e-06	2.11e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—POMC—kidney cancer	3.19e-06	2.09e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—POMC—kidney cancer	3.19e-06	2.09e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HIF1A—kidney cancer	3.18e-06	2.09e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HIF1A—kidney cancer	3.18e-06	2.09e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MTOR—kidney cancer	3.18e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TSC2—kidney cancer	3.17e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TSC2—kidney cancer	3.17e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MTOR—kidney cancer	3.17e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CD4—kidney cancer	3.16e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL2—kidney cancer	3.15e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KDR—kidney cancer	3.14e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTGS2—kidney cancer	3.14e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—RAF1—kidney cancer	3.14e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—RAF1—kidney cancer	3.14e-06	2.06e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.13e-06	2.05e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—POMC—kidney cancer	3.13e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CDKN1B—kidney cancer	3.12e-06	2.04e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CDKN1B—kidney cancer	3.12e-06	2.04e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.12e-06	2.04e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—ERBB2—kidney cancer	3.11e-06	2.04e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—ERBB2—kidney cancer	3.11e-06	2.04e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GSTP1—kidney cancer	3.07e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—JUN—kidney cancer	3.07e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MTOR—kidney cancer	3.07e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MTOR—kidney cancer	3.07e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CD4—kidney cancer	3.06e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CD4—kidney cancer	3.06e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL2—kidney cancer	3.05e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL2—kidney cancer	3.05e-06	2e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CTNNB1—kidney cancer	3.04e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KDR—kidney cancer	3.04e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KDR—kidney cancer	3.04e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—kidney cancer	3.04e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—kidney cancer	3.04e-06	1.99e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CDKN1B—kidney cancer	2.98e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CDKN1B—kidney cancer	2.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—JUN—kidney cancer	2.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—JUN—kidney cancer	2.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PTEN—kidney cancer	2.97e-06	1.94e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CTNNB1—kidney cancer	2.94e-06	1.93e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CTNNB1—kidney cancer	2.94e-06	1.93e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL2—kidney cancer	2.92e-06	1.91e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ABCB1—kidney cancer	2.91e-06	1.91e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KIT—kidney cancer	2.9e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APC—kidney cancer	2.9e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1B—kidney cancer	2.88e-06	1.89e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1B—kidney cancer	2.88e-06	1.89e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PTEN—kidney cancer	2.87e-06	1.88e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PTEN—kidney cancer	2.87e-06	1.88e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCND1—kidney cancer	2.85e-06	1.87e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—JUN—kidney cancer	2.84e-06	1.86e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GSTM1—kidney cancer	2.82e-06	1.85e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.82e-06	1.85e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CTNNB1—kidney cancer	2.82e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CTNNB1—kidney cancer	2.81e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KIT—kidney cancer	2.8e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KIT—kidney cancer	2.8e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APC—kidney cancer	2.8e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APC—kidney cancer	2.8e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—MAPK3—kidney cancer	2.77e-06	1.82e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—POMC—kidney cancer	2.76e-06	1.81e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PTEN—kidney cancer	2.75e-06	1.8e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTEN—kidney cancer	2.74e-06	1.8e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—BRAF—kidney cancer	2.72e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CTNNB1—kidney cancer	2.72e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CTNNB1—kidney cancer	2.72e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—MAPK3—kidney cancer	2.68e-06	1.76e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—MAPK3—kidney cancer	2.68e-06	1.76e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—POMC—kidney cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—POMC—kidney cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—kidney cancer	2.65e-06	1.74e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—kidney cancer	2.65e-06	1.74e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—MAPK1—kidney cancer	2.64e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—kidney cancer	2.63e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—kidney cancer	2.63e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—kidney cancer	2.63e-06	1.72e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—kidney cancer	2.59e-06	1.7e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.57e-06	1.69e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—POMC—kidney cancer	2.56e-06	1.68e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—MAPK1—kidney cancer	2.55e-06	1.67e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—MAPK1—kidney cancer	2.55e-06	1.67e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—kidney cancer	2.54e-06	1.67e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—kidney cancer	2.54e-06	1.67e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK3—kidney cancer	2.53e-06	1.66e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—kidney cancer	2.49e-06	1.64e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—kidney cancer	2.49e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—kidney cancer	2.49e-06	1.63e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—kidney cancer	2.48e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK3—kidney cancer	2.45e-06	1.61e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK3—kidney cancer	2.45e-06	1.61e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK1—kidney cancer	2.41e-06	1.58e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—kidney cancer	2.41e-06	1.58e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—kidney cancer	2.41e-06	1.58e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK3—kidney cancer	2.35e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK3—kidney cancer	2.34e-06	1.53e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—POMC—kidney cancer	2.33e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK1—kidney cancer	2.33e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK1—kidney cancer	2.33e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—kidney cancer	2.29e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—kidney cancer	2.29e-06	1.5e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—kidney cancer	2.28e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—kidney cancer	2.28e-06	1.49e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—kidney cancer	2.28e-06	1.49e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RAF1—kidney cancer	2.27e-06	1.49e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK3—kidney cancer	2.26e-06	1.48e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK3—kidney cancer	2.26e-06	1.48e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RELA—kidney cancer	2.26e-06	1.48e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—kidney cancer	2.25e-06	1.47e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK1—kidney cancer	2.23e-06	1.46e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK1—kidney cancer	2.23e-06	1.46e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MTOR—kidney cancer	2.22e-06	1.46e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—kidney cancer	2.22e-06	1.45e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—kidney cancer	2.22e-06	1.45e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—kidney cancer	2.21e-06	1.45e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—kidney cancer	2.21e-06	1.45e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—kidney cancer	2.2e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—kidney cancer	2.2e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—kidney cancer	2.2e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—kidney cancer	2.2e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RAF1—kidney cancer	2.2e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RAF1—kidney cancer	2.2e-06	1.44e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.2e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RELA—kidney cancer	2.19e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RELA—kidney cancer	2.19e-06	1.44e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—kidney cancer	2.18e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—kidney cancer	2.18e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—kidney cancer	2.18e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK1—kidney cancer	2.15e-06	1.41e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK1—kidney cancer	2.15e-06	1.41e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MTOR—kidney cancer	2.15e-06	1.41e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MTOR—kidney cancer	2.15e-06	1.41e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—kidney cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—kidney cancer	2.1e-06	1.38e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—kidney cancer	2.09e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1B—kidney cancer	2.08e-06	1.37e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—kidney cancer	2.04e-06	1.34e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—kidney cancer	2.04e-06	1.34e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—kidney cancer	2.03e-06	1.33e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—kidney cancer	2.03e-06	1.33e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—kidney cancer	2.02e-06	1.33e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—kidney cancer	2.02e-06	1.33e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1B—kidney cancer	2.01e-06	1.32e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1B—kidney cancer	2.01e-06	1.32e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—POMC—kidney cancer	1.99e-06	1.31e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—kidney cancer	1.99e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JUN—kidney cancer	1.98e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—kidney cancer	1.97e-06	1.29e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—kidney cancer	1.97e-06	1.29e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—kidney cancer	1.97e-06	1.29e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—kidney cancer	1.94e-06	1.27e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—kidney cancer	1.93e-06	1.27e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—kidney cancer	1.92e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—kidney cancer	1.92e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JUN—kidney cancer	1.92e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JUN—kidney cancer	1.92e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—kidney cancer	1.92e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—kidney cancer	1.9e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—kidney cancer	1.9e-06	1.25e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—kidney cancer	1.87e-06	1.23e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—kidney cancer	1.87e-06	1.23e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—kidney cancer	1.87e-06	1.23e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—kidney cancer	1.86e-06	1.22e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—kidney cancer	1.85e-06	1.22e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—kidney cancer	1.85e-06	1.22e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—kidney cancer	1.78e-06	1.17e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—kidney cancer	1.73e-06	1.14e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—kidney cancer	1.68e-06	1.1e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—kidney cancer	1.68e-06	1.1e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK3—kidney cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—kidney cancer	1.62e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—kidney cancer	1.62e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—kidney cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—kidney cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK3—kidney cancer	1.58e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK3—kidney cancer	1.58e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—kidney cancer	1.56e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—kidney cancer	1.56e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK1—kidney cancer	1.56e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—kidney cancer	1.54e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—kidney cancer	1.54e-06	1.01e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.53e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK1—kidney cancer	1.51e-06	9.89e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK1—kidney cancer	1.51e-06	9.89e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—kidney cancer	1.47e-06	9.66e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—kidney cancer	1.42e-06	9.34e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—kidney cancer	1.42e-06	9.34e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—kidney cancer	1.39e-06	9.1e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—kidney cancer	1.35e-06	8.87e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—kidney cancer	1.31e-06	8.58e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—kidney cancer	1.31e-06	8.58e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—kidney cancer	1.31e-06	8.58e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—kidney cancer	1.27e-06	8.3e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—kidney cancer	1.27e-06	8.3e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.26e-06	8.24e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.15e-06	7.51e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.79e-07	6.42e-06	CbGpPWpGaD
